Digital Health Marketing and Communication Officer - AA0421
The CoLive Voiceresearch project aims to identify vocal biomarkers of severe conditions andfrequent health symptoms. It is an international project based on digitaltechnologies and artificial intelligence. This research initiative is handledby the Deep Digital Phenotyping Research Unit from the Luxembourg Institute ofHealth.
.Net Software Developer - MS0421
The IT-X-HD unit is a newly-formed team dedicated to providing IT and data analysis solutions for researchers and principal investigators (PIs) at LIH. By joining our team, you will be involved in projects concerning public health research and various other support activities for our national partners, e.g. the Ministry of Health.
Postdoc position in Data Science and Web Development - MS0421
The IT-X-HD unit isa team dedicated to providing IT and data analysis solutions for researchersand principal investigators (PIs) at LIH. By joining our team, you will beinvolved in projects concerning digital health research and various othersupport activities for our national partners, e.g. the Ministry of Health orother academic institutions.
Biobank Technician - KB0421
The Biobank Technician is responsible for proper reception, processing, efficienttracking, optimal storage, logistics, handling and documentation of samples forprojects managed at IBBL. Under the supervision of the Head of Biorepository, s/he is also responsible for maintaining the related laboratory areas, theirtidiness and functionality in compliance with quality system requirements.
02 June 2021 01:00 PM
WEBINAR: How to plan and perform clinical trials during and after the COVID-19 pandemic (LIH-EFGCP GCP Refresher Training)
Clinical Research Project Manager - CB0321
TheClinical Research Project Manager takes in charge every step of the clinicalresearch projects (lead, design, setup according to procedures, initiation,operation and closure) involving internal and external parties. He/she ensuresdeliverables are achieved and budgets met. He/she also provides specificexpertise and know-how in clinical research/biobanking.
Vocal Biomarkers: What our voice tells us about our health
A voice reveals a lot about a person’s health: Does it sound strong? Does it sound weak? Is it hoarse? Are there indications of pain or fatigue? Modern digital technologies have recently made it possible to detect the smallest changes in the voice. But now, more research is needed to make the results of this voice monitoring usable for medical and diagnostic purposes. To this end, a team at the Luxembourg Institute of Health (LIH) led by Dr. Guy Fagherazzi, director of the Department of Population Health and head of the Deep Digital Phenotyping Research Unit, has written a review on the topic of “vocal biomarkers”. In this paper, the research team describes the state of the art of voice analysis for health purposes and the evaluation of speech recordings with the help of artificial intelligence. The scientists have also described a pipeline in which the corresponding techniques can be coordinated and used for all the way up to medical applications. They have thus created an important basis for systematically advancing voice analysis in the field of digital health and making it ready for use in clinical practice. The publication “Voice For Health: The Use Of Vocal Biomarkers From Research To Clinical Practice” was published on April 16th in the journal “Digital Biomarkers“
New insights into the genetic risk factors of Lewy body dementia
Prof Rejko Krüger, Director of Transversal Translational Medicine at LIH, contributed to an international study aiming to shed light into the genetic determinants of Lewy body dementia (LBD), a common yet understudied neurodegenerative disease. Leveraging advanced genome sequencing techniques in a large study population, the scientists identified five risk genes involved in the onset and progression of this form of dementia, and brought forward the critical role of mutations in a subset of these genes in LBD development. The study also showed that LBD displays common features with Alzheimer’s disease and Parkinson’s disease, thereby providing a deeper understanding of the complex genetic architecture of this age-related neurodegenerative condition and paving the way for the development of targeted therapies. The findings were published in February 2021 in the prestigious journal Nature Genetics.